Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines
Contrast-enhanced (CE)US using Sonazoid with KLCA-NCC 2022 guidelines is highly effective for HCC diagnosis. KLCA-NCC 2022 criteria showed high accuracy, 96.2% sensitivity, and 98.9% PPV. CEUS demonstrated excellent inter-reader consistency in detecting arterial phase hyperenhancement and Kupffer defects.
Authors
- Kaiyan Li (ORCID: https://orcid.org/0000-0003-3332-6325)
- Rong-Hua Zhu
- Zhe Huang (ORCID: https://orcid.org/0000-0002-3477-8326)
- Shanshan Li (ORCID: https://orcid.org/0000-0002-9021-8470)
- Hongchang Luo
Institutions
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Insights into Imaging
- Published
- 2024-10-31
- DOI
- https://doi.org/10.1186/s13244-024-01838-x
- Citations
- 2
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.74